Isomorphic Lab’s proprietary drug-discovery model is a major advance, but scientists developing open-source tools are left ...

Google DeepMind cofounder and CEO Demis Hassabis and John Jumper, a senior researcher at the company, shared the 2024 Nobel Prize for Chemistry for their work on AlphaFold, an AI model that predicts ...

Mapping proteins unlocks clues to preventing and treating illnesses. Here’s how DeepMind’s AlphaFold is accelerating this research exponentially.

Add Yahoo as a preferred source to see more of our stories on Google. In April 2025, Isomorphic Labs raised a $600 million in its first-ever external funding round, led by Thrive Capital. Alphabet’s ...

Over the past six years, artificial intelligence has been significantly influenced by 12 foundational research papers. One ...

Google's new initiative is integrating advanced artificial intelligence into Indian classrooms, labs, and fields, opening unprecedented career opportunities for students.

Read Jennifer Doudna’s tribute to Demis Hassabis here. Demis Hassabis learned he had won the 2024 Nobel Prize in Chemistry ...

(Bloomberg) -- Google DeepMind spinoff Isomorphic Labs expects research of drugs it designed using artificial intelligence will begin this year, according to its Nobel Prize-winning chief executive ...

While many businesses continue to seek AI’s killer app, biochemists have already found it. That application is protein folding. This week marks the five-year anniversary of the debut of Alpha Fold 2, ...